[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Flangea et al., 2013 - Google Patents

Testing the feasibility of fully automated chip‐based nanoelectrospray ionization mass spectrometry as a novel tool for rapid diagnosis of Fabry disease

Flangea et al., 2013

View PDF
Document ID
1857296307712778709
Author
Flangea C
Mosoarca C
Cozma C
Galusca M
Przybylski M
Zamfir A
Publication year
Publication venue
Electrophoresis

External Links

Snippet

Fabry condition, a lysosomal storage disease (LSD) is characterized by the absence or reduction of the α‐galactosidase A activity. Recently, a new diagnostic method for detection of α‐galactosidase activity from dried blood spots (DBS) using a chemical substrate and …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases

Similar Documents

Publication Publication Date Title
Qin et al. A strategy for rapid, high-confidence protein identification
Ando et al. Alkyne-tag SERS screening and identification of small-molecule-binding sites in protein
Yao et al. Proteolytic 18O labeling for comparative proteomics: model studies with two serotypes of adenovirus
Zybailov et al. Statistical analysis of membrane proteome expression changes in Saccharomyces c erevisiae
Molina et al. Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry
Swales et al. Mass spectrometry imaging of cassette-dosed drugs for higher throughput pharmacokinetic and biodistribution analysis
Arrell et al. Cardiovascular proteomics: evolution and potential
Manier et al. Reagent precoated targets for rapid in-tissue derivatization of the anti-tuberculosis drug isoniazid followed by MALDI imaging mass spectrometry
Theberge et al. Characterization of transthyretin mutants from serum using immunoprecipitation, HPLC/electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry
JP6180423B2 (en) Lysosomal enzyme assays and compositions
Zhu et al. Glycopeptide site heterogeneity and structural diversity determined by combined lectin affinity chromatography/IMS/CID/MS techniques
Chennamaneni et al. Improved reagents for newborn screening of mucopolysaccharidosis types I, II, and VI by tandem mass spectrometry
Frey et al. Chemical derivatization of peptide carboxyl groups for highly efficient electron transfer dissociation
la Marca et al. New strategy for the screening of lysosomal storage disorders: the use of the online trapping-and-cleanup liquid chromatography/mass spectrometry
Mills et al. Synthesis of novel internal standards for the quantitative determination of plasma ceramide trihexoside in Fabry disease by tandem mass spectrometry
Maynard et al. Methods for enrichment and assignment of N-acetylglucosamine modification sites
Zhu et al. Residue-specific mass signatures for the efficient detection of protein modifications by mass spectrometry
Stefansson et al. Regulation of multimer formation in electrospray mass spectrometry
Cheng et al. Online monitoring of enzymatic reactions using time-resolved desorption electrospray ionization mass spectrometry
Walker et al. Interplay of permanent charge and hydrophobicity in the electrospray ionization of glycans
Cheow et al. Simultaneous Enrichment of Plasma Soluble and Extracellular Vesicular Glycoproteins Using Prolonged Ultracentrifugation-Electrostatic Repulsion-hydrophilic Interaction Chromatography (PUC-ERLIC) Approach*[S]
Randall et al. MALDI imaging of liquid extraction surface analysis sampled tissue
Jager et al. Determination of tamoxifen and endoxifen in dried blood spots using LC–MS/MS and the effect of coated DBS cards on recovery and matrix effects
Maekawa et al. Cutting‐edge LC–MS/MS applications in clinical mass spectrometry: Focusing on analysis of drugs and metabolites
Pu et al. High-throughput intact protein analysis for drug discovery using infrared matrix-assisted laser desorption electrospray ionization mass spectrometry